Revco
Executive Summary
New top operating officer, President William Edwards, joined the drug chain at an initial annual salary of $425,000, according to proxy materials prepared for Revco's Sept. 27 annual meeting. Edwards was previously the president of a deep-discounting drug chain in Detroit, F&M Distributors.
You may also be interested in...
Servier and MiNA Target Neurodegenerative Disease With Novel RNA Therapy
Already partnering with AZ and Boehringer Ingelheim in liver targets, the UK biotech sees potential to hit ‘undruggable’ CNS targets as well.
COVID-19: FDA Schedules 4 More Virtual Town Halls Through February
The US agency has announced another month of webinars aimed at labs and manufacturers that are (or have) developed diagnostic tests for the novel coronavirus.
GSK Ends Tough Week With Ulcerative Colitis Therapy Termination
If bad luck comes in threes, GSK will be delighted to see the end of this week with dostarlimab approval delayed, bintrafusp failing in lung cancer and a Phase II of an ulcerative colitis drug discontinued.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: